WellDoc™ Mobile Diabetes Management Randomized Controlled Trial: Change in Clinical and Behavioral Outcomes and Patient and Physician Satisfaction
| Autor: | Suzanne Sysko Clough, Ann L. Gruber-Baldini, Maria C. Okafor, James M. Minor, Charlene C. Quinn, Dan Lender |
|---|---|
| Rok vydání: | 2008 |
| Předmět: |
Adult
Male medicine.medical_specialty Endocrinology Diabetes and Metabolism MEDLINE Comorbidity Type 2 diabetes Body Mass Index law.invention User-Computer Interface Endocrinology Patient satisfaction Patient Education as Topic Public Relations Randomized controlled trial law Diabetes management Physicians Diabetes mellitus Diabetes Mellitus Humans Hypoglycemic Agents Medicine Glycemic Glycated Hemoglobin Physician-Patient Relations Maryland business.industry Patient Selection Teaching Middle Aged medicine.disease Medical Laboratory Technology Patient Satisfaction Physical therapy Female business Mobile Health Units |
| Zdroj: | Diabetes Technology & Therapeutics. 10:160-168 |
| ISSN: | 1557-8593 1520-9156 |
| DOI: | 10.1089/dia.2008.0283 |
| Popis: | Less than 63% of individuals with diabetes meet professional guidelines target of hemoglobin A1c7.0%, and only 7% meet combined glycemic, lipid, and blood pressure goals. The primary study aim was to assess the impact on A1c of a cell phone-based diabetes management software system used with web-based data analytics and therapy optimization tools. Secondary aims examined health care provider (HCP) adherence to prescribing guidelines and assessed HCPs' adoption of the technology.Thirty patients with type 2 diabetes were recruited from three community physician practices for a 3-month study and evenly randomized. The intervention group received cell phone-based software designed by endocrinologists and CDEs (WellDoc Communications, Inc., Baltimore, MD). The software provided real-time feedback on patients' blood glucose levels, displayed patients' medication regimens, incorporated hypo- and hyperglycemia treatment algorithms, and requested additional data needed to evaluate diabetes management. Patient data captured and transferred to secure servers were analyzed by proprietary statistical algorithms. The system sent computer-generated logbooks (with suggested treatment plans) to intervention patients' HCPs.The average decrease in A1c for intervention patients was 2.03%, compared to 0.68% (P0.02, one-tailed) for control patients. Of the intervention patients, 84% had medications titrated or changed by their HCP compared to controls (23%, P = 0.002). Intervention patients' HCPs reported the system facilitated treatment decisions, provided organized data, and reduced logbook review time.Adults with type 2 diabetes using WellDoc's software achieved statistically significant improvements in A1c. HCP and patient satisfaction with the system was clinically and statistically significant. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|